Here is why Seneca Biopharma Inc. (SNCA) stock volatility recorded over the last month was 7.38%

Seneca Biopharma Inc. (SNCA) is priced at $0.68 after the most recent trading session. At the very opening of the session, the stock price was $0.6577 and reached a high price of $0.6851, prior to closing the session it reached the value of $0.66. The stock touched a low price of $0.6405.

Recently in News on September 10, 2020, Seneca Biopharma, Inc. Announces Completion of Phase II Clinical Study in China for the Treatment of Ischemic Stroke. Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the last subject completed their final follow-up assessment in the Company’s non-GCP Phase II study in Beijing, China evaluating NSI-566 for the treatment of chronic ischemic stroke. With this milestone achieved, the company remains on schedule to release top line data for the study during the fourth quarter of 2020. You can read further details here


My Next COVID-19 Stock Alert Poised For Triple Digit Moves

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<

Sponsored


Seneca Biopharma Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.0900 on 01/17/20, with the lowest value was $0.5000 for the same time period, recorded on 03/18/20.

Seneca Biopharma Inc. (SNCA) full year performance was -50.75%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Seneca Biopharma Inc. shares are logging -83.28% during the 52-week period from high price, and 36.76% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.50 and $4.09.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1472222 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Seneca Biopharma Inc. (SNCA) recorded performance in the market was -33.33%, having the revenues showcasing -16.35% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 11.71M, as it employees total of 5 workers.

Specialists analysis on Seneca Biopharma Inc. (SNCA)

During the last month, 2 analysts gave the Seneca Biopharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.7219, with a change in the price was noted -0.2317. In a similar fashion, Seneca Biopharma Inc. posted a movement of -26.00% for the period of last 100 days, recording 555,354 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SNCA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Trends and Technical analysis: Seneca Biopharma Inc. (SNCA)

Raw Stochastic average of Seneca Biopharma Inc. in the period of last 50 days is set at 62.85%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 60.10%. In the last 20 days, the company’s Stochastic %K was 62.56% and its Stochastic %D was recorded 71.45%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -33.33%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -16.85%, alongside a downfall of -50.75% for the period of the last 12 months. The shares increased approximately by -1.48% in the 7-day charts and went down by 18.07% in the period of the last 30 days. Common stock shares were lifted by -16.35% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the Investchronicle.com pre-market morning brief 100% free